What to Do if Your GLP-1 Medication is Denied by Insurance

Learn the steps to appeal an insurance denial for GLP-1 medications and improve your chances of coverage.

Understanding Denial Reasons

Insurance denials for GLP-1 medications can occur for various reasons. Common denial reasons include: plans excluding weight-loss drugs entirely, lack of documented BMI or comorbidities, incomplete step therapy, off-label use requests, missing diet/lifestyle program documentation, or the drug not being on the plan's formulary.

Steps to Appeal a Denial

If your GLP-1 medication is denied, you can follow an appeal ladder to challenge the decision:

1. **Internal Appeal #1**: Submit a letter of medical necessity that ties your documented medical record to each criterion required by the insurance plan.

2. **Peer-to-Peer Review**: Your prescriber can speak directly with the plan's medical director to advocate for your case.

3. **Internal Appeal #2**: If new documentation becomes available, submit it to support your appeal.

4. **External Review**: If the internal appeals are unsuccessful, you can request an independent review from a neutral third party. This step is crucial for determining whether the denial was based on benefit exclusion or medical necessity.

Improving Your Chances of Approval

To enhance the likelihood of approval, ensure that your request is framed around a qualifying medical condition. For instance, Wegovy is covered for reducing cardiovascular risk in adults with established cardiovascular disease and obesity. Additionally, if you have a diagnosis of type 2 diabetes, framing the request around that can lead to better coverage outcomes. Documented comorbidities like sleep apnea, hypertension, or dyslipidemia can also help move a BMI-27 patient into a covered tier.

What to Do if Coverage is Not Available

If your plan has a hard benefit exclusion for weight-loss drugs, appeals may not change this. In such cases, consider pivoting to a covered indication, exploring the Medicare Bridge, or looking into cash-pay options. Self-pay programs for GLP-1 medications are available, such as Wegovy and Zepbound, which do not require insurance.